Imam H. Shaik - Concepedia

Author

Imam H. Shaik

Texas Tech University Health Sciences Center ORCID

Also Known As

Cynthia Sedik, Imam H Shaik, Imam H. Shaik, Imam Hussain Shaik, Imam Shaik, Imam Shaik Imam Shaik, Katherine Sanders, Lemasters, John J., Lorna McInroy

Publications

12.8K

Citations

H-Index

Concepts

All Affiliations

Texas Tech University Health Sciences Center Texas Tech University University Hospital Southampton NHS Foundation Trust University of Southampton Jenner Institute

About

Imam H. Shaik is an author at Texas Tech University Health Sciences Center specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	4K
2	Health Sciences	5	5	237
3	Public Health	2	2	146
4	Social Sciences	1	1	10
5	Anesthesia	1	1	10

Imam H. Shaik

Publications

10.5K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, The Lancet VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary Report	2020	2.6K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Xinxue Liu, R. H. Shaw, Arabella Stuart, The Lancet VaccinationVaccine SafetyVaccine DevelopmentAdenoviral VectoredImmunology	2021	539
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays Kevin R. Bewley, Naomi S. Coombes, Luc Gagnon, Nature Protocols Virus Neutralization AssaysViral DiagnosticsViral PathogenesisImmunologyAntiviral Response	2021	317
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial Alasdair Munro, Shuo Feng, Leila Janani, The Lancet Infectious Diseases	2022	170
Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples Imam H. Shaik, Reza Mehvar Analytical and Bioanalytical Chemistry BiochemistryNew Thiol-masking ReagentMedicineLiver PhysiologyBioanalysis	2006	128
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension Vivek Gupta, Nilesh Gupta, Imam H. Shaik, Journal of Controlled Release HypertensionPulmonary Arterial HypertensionPulmonary CirculationLiposomal FasudilMedicine	2013	117
Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery Omar M. Young, Imam H. Shaik, Roxanna Twedt, American Journal of Obstetrics and Gynecology Cesarean DeliveryObese GravidaePharmacologyCefazolin ProphylaxisMaternal Health	2015	60
Protective Effects of Diallyl Sulfide, a Garlic Constituent, on the Warm Hepatic Ischemia–Reperfusion Injury in a Rat Model Imam H. Shaik, Jancy M. George, Thomas Thekkumkara, Pharmaceutical Research Garlic ConstituentDiallyl SulfideBiochemistryReperfusion InjuryMedicine	2008	59

Page 1